Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) – Equities researchers at William Blair issued their Q1 2025 earnings per share estimates for shares of Axsome Therapeutics in a report released on Tuesday, May 9th. William Blair analyst M. Minter forecasts that the company will post earnings of ($0.34) per share for the quarter. The consensus […]
Axsome Therapeutics (NASDAQ:AXSM – Get Rating) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday. AXSM has been the topic of a number of other reports. HC Wainwright reaffirmed a “buy” rating and issued a $200.00 price target on shares of […]
Axsome Therapeutics (NASDAQ:AXSM – Get Rating) is scheduled to be posting its quarterly earnings results before the market opens on Monday, May 8th. Analysts expect Axsome Therapeutics to post earnings of ($1.12) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link. Axsome […]
WCM Investment Management LLC lessened its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) by 33.6% in the fourth quarter, HoldingsChannel.com reports. The fund owned 88,739 shares of the company’s stock after selling 44,966 shares during the period. WCM Investment Management LLC’s holdings in Axsome Therapeutics were worth $6,844,000 at the end […]
Should You Buy or Sell Axsome Therapeutics Stock? Get The Latest AXSM Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.